Heidi Van den Bulck

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters

Barbara Brouwers, Sigrid Hatse, Lissandra Dal Lago et al. · Oncotarget · 2016 · 52 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study

Cindy Kenis, Lore Decoster, Johan Flamaing et al. · BMC Geriatrics · 2022 · 32 citations · Full text

Medicine, Geriatric Medicine, Oncology +13

Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors

Elke Lodewijckx, Cindy Kenis, Johan Flamaing et al. · Journal of Geriatric Oncology · 2020 · 25 citations · Full text

Medicine, Geriatric Medicine, Oncology +16

Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group

Ignace Vergote, Philip R. Debruyne, Frédéric Kridelka et al. · Gynecologic Oncology · 2015 · 22 citations

Medicine, Gynecology, Oncology +9